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To get a better insight into the antimicrobial potency of short cationic lipopeptides, 35
new entities were synthesized using solid phase peptide strategy. All newly obtained
lipopeptides were designed to be positively charged from +1 to +4. This was achieved
by introducing basic amino acid - lysine - into the lipopeptide structure and had a
hydrophobic fatty acid chain attached. Lipopeptides were subjected to microbiological
tests using reference strains of Gram-negative bacteria: Escherichia coli, Klebsiella
pneumoniae, Proteus vulgaris, Pseudomonas aeruginosa, Gram-positive bacteria:
Staphylococcus aureus, Staphylococcus epidermidis, Bacillus subtilis, Enterococcus
faecalis, and fungi: Candida albicans, Candida tropicalis, Aspergillus brasiliensis. The
minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC)
and minimal fungicidal concentration (MFC) were established for each strain. The
toxicity toward human cells was determined by hemolysis tests via minimum hemolytic
concentration (MHC) determination. The effect of the trifluoroacetic acid (TFA) counter
ion on the antimicrobial activity of lipopeptides was also examined by its removing and
performing the antimicrobial tests using counter ion-free compounds. The study shows
that lipopeptides are more potent against Gram-positive than Gram-negative strains. It
was revealed that positive charge equals at least +2 is a necessary condition to observe
significant antimicrobial activity, but only when it is balanced with a proper length of
hydrophobic fatty acid chain. The hemolytic activity of lipopeptides strongly depends
on amino acid composition of the hydrophilic portion of the molecule as well as fatty
acid chain length. Compounds endowed with a greater positive charge were more toxic
to human erythrocytes. This should be considered during new lipopeptide molecules
design. Our studies also revealed the TFA counter ion has no significant effect on the
antimicrobial behavior of cationic lipopeptides.
Keywords: lipopeptides, antimicrobial activity, MIC, MBC, TFA counter ion, fatty acid chain length
Abbreviations: AMP, antimicrobial peptide; Boc, tert-butoxycarbonyl; CFU, colony forming units; CLSI,
Clinical and Laboratory Standards Institute; DCM, dichloromethane; DIC, diisopropylcarbodiimide; DMF, N,N-
dimethylformamide; Fmoc, 9-fluorenylmethoxycarbonyl, G−, Gram-negative bacteria; G+, Gram positive bacteria;
HOBt, 1-hydroxybenzotriazole; MBC, minimum bactericidal concentration; MFC, minimum fungicidal concentration; MIC,
minimum inhibitory concentration; TFA, trifluoroacetic acid; TIS, triisopropylosilane.
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INTRODUCTION
Most naturally occurring antimicrobial peptides are positively
charged and their amino acid sequences form an amphipathic
structure. These structural conditions seem to be mandatory for
the occurrence of high levels of antimicrobial activity (Hancock
and Diamond, 2000; Brown and Hancock, 2006; Hancock and
Sahl, 2006). Therefore, antimicrobial peptide molecule design
and the synthesis of positively charged antimicrobial peptide
compounds are often achieved by introducing basic amino acids,
e.g., lysine or arginine, into the sequence. In turn, the condition
of amphipathicity is provided by introducing amino acids with
hydrophobic side chains. It is also possible to create amphiphilic
peptide-like molecule by replacing a few hydrophobic amino
acid residues with one, also hydrophobic, fatty acid chain.
(Makovitzki et al., 2006; Domalaon et al., 2016). A large group
of potent antimicrobial lipopeptides have been generated
this way. Some of them, e.g., surotomycin, dalbavancin and
HB1345, are currently being developed by the pharmaceutical
industry and are undergoing clinical trials (Greber and Dawgul,
2016). The emergence and spread of multidrug resistant
(MDR) microorganisms causes that a development of a new
antibiotics is nowadays one of the most important challenges
of pharmaceutical chemistry (Ventola, 2015). Due to the issue
of researching of an effective antibiotic therapies is urgent,
we decided to synthesize a group of potentially antimicrobial
cationic lipopeptides and study their antibacterial and antifungal
potency. Our lipopeptides are divided into five groups differing
in fatty acid chain length and cationic net charge. In the present
study, we determined the antibacterial and antifungal potency
of lipopeptides toward 11 reference strains of Gram-negatives:
Escherichia coli, Klebsiella pneumoniae, Proteus vulgaris,
Pseudomonas aeruginosa, Gram-positives: Staphylococcus
aureus, Staphylococcus epidermidis, Bacillus subtilis, Enterococcus
faecalis, and fungi: Candida albicans, Candida tropicalis, and
Aspergillus brasiliensis. The minimum inhibitory concentration
(MIC), minimum bactericidal concentration (MBC) and
minimal fungicidal concentration (MFC) were established for
each strain. The toxicity toward human cells was tested via
minimum hemolytic concentration (MHC) determination.
Solid phase peptide synthesis procedure, employed in this
work, as well as chromatographic purification of lipopeptides
requires use of trifluoroacetic acid. This means that cationic
lipopeptides are obtained as trifluoroacetate salts. Due to the
fact that trifluoroacetic ion is not a physiological and it is not
present in the common microbial environment it may have an
impact on microbial growth. We decided to study if there is a
difference in antimicrobial activity of lipopeptides in the form of
trifluoroacetic salts and lipopeptides in the form of bases. There
is no other data published in this matter.
MATERIALS AND METHODS
Chemicals
All chemicals and solvents for peptide synthesis were from
Iris Biotech (Germany). The column for lipopeptide RP-HPLC
purification (Nucleodur C8e/c, 100 Å, 5 µm, 250 × 10mm)
was from Macherey-Nagel (Germany). The analytical column
for peptide characterization (Chromolith Performance RP-18e,
100 × 4.6mm) was from Merck Millipore (Germany). The
gradient grade acetonitrile was from Scharlau (Spain). Deionized
water (18.2 M’) was obtained using a Direct-Q 3 UV-R
Ultrapure Water System, Merck-Millipore, (Germany). The ion
exchange device for TFA removal was a VariPure IPE (Ion Pair
Extraction), Agilent (USA).
Peptide Synthesis and Purification
All lipopeptides were synthesized using the Fmoc/tBu procedure
on Fmoc-Rink Amide AM resin (0.59 mmol/g) (Table 1). The
Fmoc protecting group of amino acid was detached by 20%
piperidine in DMF. Peptide bond formation was carried out
with a 3-fold excess of Fmoc-protected amino acid dissolved
in a DMF/DCM mixture (1:1 v/v) in the presence of 1%
of Triton X-100 using DIC and HOBt as coupling reagents.
Removal of the side chain protecting group and cleavage from
the resin was achieved via 95% TFA with 2.5% of TIS and
2.5% of water for 1 h (Chan and White, 2000). The cleaved
lipopeptides were precipitated and lyophilized. They were then
purified by semi-preparative reverse-phase high performance
liquid chromatography (RP-HPLC) with a Macharey Nagel C8
e/c column and eluted with a 20–60% linear gradient of phase B
(phase A—0.1% TFA in water, phase B—0.1% TFA in ACN), at a
flow rate of 3mL/min, and analyzed at 214 nm.
Reversed-Phase Analysis of Lipopeptides
The lipopeptides were analyzed by RP-HPLC on a Chromolith
Performance monolithic column with a linear gradient 2–98%
phase B (where phase A was 0.1% TFA in water and phase
B was 0.1% TFA in ACN), at a flow rate of 2 mL/min, and
analyzed at 214 nm. Fractions with a purity greater than 95%
were collected and freeze-dried on an Alpha 2–4 LD plus system
(Christ, Germany). Lipopeptides were further characterized by
matrix assisted laser desorption ionization time-of-flight mass
spectrometry (MALDI-TOF, Bruker, Germany).
Organisms and Antimicrobial Assay
The minimum inhibitory concentration (MIC), minimum
bactericidal concentration (MBC) and minimum fungicidal
concentration (MFC) were determined according to the
procedure recommended by the Clinical Laboratory Standards
Institute (CLSI). The following reference strains were tested:
Gram-negative E. coli (ATCC 25922), K. pneumoniae (ATCC
700603), P. vulgaris (PCM 2668), P. aeruginosa (ATCC 9027),
Gram-positive S. aureus (ATCC 25923), S. epidermidis (PCM
2118), B. subtilis (ATCC 6633), E. faecalis (ATCC 29212) and
fungi C. albicans (ATCC 10231), C. tropicalis (PCM 2681),
and A. brasiliensis (ATCC 16404). All the microorganisms
were from the Polish Collection of Microorganisms (Wroclaw,
Poland). MIC was determined using a microbroth dilution
method with Mueller-Hinton (MH) broth for bacteria and
Sabouraud Dextrose broth for fungi (Becton Dickinson, Le
Pont de Claix, France). An initial inoculum of 105 cfu/mL
was used for bacteria and 103 cfu/mL for fungi. Polypropylene
96-well plates (Kartell, Noviglio, Italy) were incubated for
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TABLE 1 | Physicochemical characterization of synthesized cationic lipopeptides.
Group number Denotation Fatty acid chain Net charge Molecular mass Retention time tR
Calculated Observed
1 C16-K-NH2 Heksadecanoic +1 383.4 384.4 8.17
C16-KK-NH2 +2 511.5 512.5 7.02
C16-KKK-NH2 +3 639.5 640.5 6.58
C16-KKKK-NH2 +4 767.6 768.6 6.20
C16-KG-NH2 +1 440.4 441.4 8.24
C16-KGK-NH2 +2 568.4 569.4 7.07
C16-KGKG-NH2 +2 625.5 626.5 7.10
2 C14-K-NH2 Tetradecanoic +1 355.4 356.4 7.22
C14-KK-NH2 +2 483.3 484.3 6.33
C14-KKK-NH2 +3 611.5 612.5 5.93
C14-KKKK-NH2 +4 739.2 740.2 5.57
C14-KG-NH2 +1 412.4 413.4 7.00
C14-KGK-NH2 +2 540.2 541.2 6.25
C14-KGKG-NH2 +2 597.4 598.4 6.31
3 C12-K-NH2 Dodecanoic +1 327.2 328.2 6.44
C12-KK-NH2 +2 455.6 456.6 5.43
C12-KKK-NH2 +3 583.2 584.2 4.92
C12-KKKK-NH2 +4 711.2 712.2 4.37
C12-KG-NH2 +1 384.4 385.4 6.52
C12-KGK-NH2 +2 512.2 513.2 5.20
C12-KGKG-NH2 +2 569.2 570.2 5.42
4 C10-K-NH2 Decanoic +1 299.3 300.3 5.22
C10-KK-NH2 +2 427.3 428.3 4.57
C10-KKK-NH2 +3 555.5 556.5 4.33
C10-KKKK-NH2 +4 683.3 684.3 4.00
C10-KG-NH2 +1 356.3 357.3 5.31
C10-KGK-NH2 +2 484.2 485.2 4.45
C10-KGKG-NH2 +2 541.3 542.3 4.68
5 C8-K-NH2 Octanoic +1 271.2 272.2 4.33
C8-KK-NH2 +2 399.3 400.3 3.54
C8-KKK-NH2 +3 527.2 528.2 3.28
C8-KKKK-NH2 +4 655.4 656.4 3.11
C8-KG-NH2 +1 328.3 329.3 4.24
C8-KGK-NH2 +2 456.4 457.4 3.58
C8-KGKG-NH2 +2 513.1 514.1 5.50
18 h at 37◦C for bacteria and for 48 h at 25◦C for the tested
fungi. MIC (µg/mL) was taken as the lowest concentration
of the lipopeptide, at which the observable growth was
inhibited. All the MIC wells which did not reveal turbidity
were cultured on solid media: a Mueller-Hinton II Agar for
bacteria and a Sabouraud 2% Glucose Agar for fungi. The
lowest concentrations of lipopeptides that did not show any
visible growth on the plates after 24 h of incubation at 37◦C and
48 h of incubation at 25◦C were recorded as MBCs and MFCs,
respectively. The experiments were performed in triplicate on
three different days.
Hemolysis
The hemolytic activity of the lipopeptides was determined
by exposing human red blood cells (4% v/v) to tested
compounds at graded concentrations. Red blood cells were
obtained from a healthy donor. EDTA was used to prevent
the blood clotting. The plasma was removed via centrifugation
and the erythrocytes were washed three times with PBS. The
red blood cells were suspended in PBS and incubated with
different concentrations of lipopeptides at 37◦C for 1 h and
centrifuged for 5min at 1000 × g. The supernatants were
transferred to a sterile 96-well plate and hemoglobin release
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TABLE 2 | Antimicrobial activity toward Gram positive strains.
Lipopeptides Staphylococcus aureus Staphylococcus epidermidis Bacillus subtillis Enterococcus fecalis
MIC MBC MIC MBC MIC MBC MIC MBC
C16-K-NH2 512 512 8 16 8 8 32 64
C16-KK-NH2 8 8 4 4 4 4 8 8
C16-KKK-NH2 8 8 4 4 8 8 16 16
C16-KKKK-NH2 4 8 4 4 4 4 16 16
C16-KG-NH2 8 8 4 4 4 4 16 16
C16-KGK-NH2 8 8 4 4 4 4 8 16
C16-KGKG-NH2 16 32 4 4 4 4 16 16
C14-K-NH2 64 64 16 16 32 32 64 64
C14-KK-NH2 64 64 4 4 4 4 32 64
C14-KKK-NH2 64 64 8 8 4 4 64 64
C14-KKKK-NH2 128 128 16 16 4 4 64 64
C14-KG-NH2 32 32 16 16 16 16 32 32
C14-KGK-NH2 64 128 16 16 8 8 64 64
C14-KGKG-NH2 64 128 32 32 16 16 64 64
C12-K-NH2 256 256 128 128 128 256 256 256
C12-KK-NH2 2·10
3 2·103 64 64 64 128 512 512
C12-KKK-NH2 1·10
3 1·103 64 64 64 128 512 512
C12-KKKK-NH2 1·10
3 1·103 64 64 128 256 512 512
C12-KG-NH2 256 512 128 128 128 256 256 256
C12-KGK-NH2 >2·10
3 1·103 64 128 512 1·103 2·103 >2·103
C12-KGKG-NH2 2·10
3 2·103 256 512 64 64 512 512
C10-K-NH2 1·10
3 >1·103 1·103 1·103 1·103 1·103 >2·103 >2·103
C10-KK-NH2 >2·10
3 >2·103 256 512 256 512 >2·103 >2·103
C10-KKK-NH2 >2·10
3 >2·103 128 256 128 256 >2·103 >2·103
C10-KKKK-NH2 >2·10
3 >2·103 64 128 128 128 >2·103 >2·103
C10-KG-NH2 >2·10
3 >2·103 512 1·103 512 512 1·103 >1·103
C10-KGK-NH2 >2·10
3 >2·103 512 512 512 1·103 >2·103 >2·103
C10-KGKG-NH2 >2·10
3 >2·103 512 512 512 1·103 2·103 >2·103
C8-K-NH2 >1·10
3 >1·103 >1·103 >1·103 >1·103 >1·103 >1·103 >1·103
C8-KK-NH2 >1·10
3 >1·103 >1·103 >1·103 >1·103 >1·103 >1·103 >1·103
C8-KKK-NH2 >2·10
3 >2·103 >256 512 1·103 1·103 >2·103 >2·103
C8-KKKK-NH2 >2·10
3 >2·103 >2·103 >2·103 >2·103 >2·103 2·103 >2·103
C8-KG-NH2 >2·10
3 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103
C8-KGK-NH2 >2·10
3 >2·103 256 1·103 512 1·103 >2·103 >2·103
C8-KGKG-NH2 >2·10
3 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103
MIC and MBC are expressed as µg/mL.
was measured with an Epoch microplate spectrophotometer
(BioTek, USA) by recording the absorbance at 550 nm. A
0.1% Triton X-100 solution was used as the positive control
(100% of hemolysis) and pure PBS as the negative (0% of
hemolysis). Minimum hemolytic concentration (MHC) was
taken as the lowest concentration which induced 10% of
hemolysis.
Removal of Trifluoroacetic Acid Counter
Ion and FTIR Spectroscopy
Removal of trifluoroacetate counter ions was performed on
VariPure IPE exchange columns. Before applying lipopeptides,
ion exchange devices were conditioned as follows: 2 × 30mL
MeOH, 2 × 30mL ACN, and 2 × 30mL purified water.
Previously lyophilized lipopeptides were dissolved in 10%
acetonitrile and applied to ion exchange columns. Lipopeptides
were eluted from the ion-exchange resin using a clean matrix.
Thus obtained counter ion-free eluates were diluted with purified
water and then subjected to a freeze-drying process. In order
to confirm the absence of trifluoroacetate counter ions in the
synthesized cationic lipopeptides, infrared spectroscopic studies
were carried out. Infrared spectra were recorded on a Jasco
FT/IR-410 spectrophotometer (Labor and Datentechnik GmbH,
Germany) using the KBr tablet method. Tablets were prepared
from 100mg of potassium bromide (KBr) and 1.5mg of the tested
lipopeptide.
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TABLE 3 | Antimicrobial activity toward Gram negative strains.
Lipopeptides Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa Proteus vulgaris
MIC MBC MIC MBC MIC MBC MIC MBC
C16-K-NH2 512 >512 512 >512 512 >512 >512 >512
C16-KK-NH2 8 8 16 16 8 8 >512 >512
C16-KKK-NH2 8 16 4 4 8 8 >512 >512
C16-KKKK-NH2 8 8 4 8 8 8 >512 >512
C16-KG-NH2 256 256 128 256 256 1·10
3 >512 >512
C16-KGK-NH2 8 8 16 16 16 32 >512 >512
C16-KGKG-NH2 16 16 16 16 8 8 >512 >512
C14-K-NH2 128 128 64 512 128 1·10
3 >512 >512
C14-KK-NH2 64 128 128 128 32 64 >512 >512
C14-KKK-NH2 128 128 128 128 32 128 >512 >512
C14-KKKK-NH2 256 256 128 256 256 512 >512 >512
C14-KG-NH2 64 64 32 32 32 64 >512 >512
C14-KGK-NH2 128 128 64 64 32 64 >512 >512
C14-KGKG-NH2 128 128 128 128 64 128 >512 >512
C12-K-NH2 256 256 256 256 128 256 >512 >1·10
3
C12-KK-NH2 2·10
3 2·103 2·103 2·103 2·103 2·103 >2·103 >2·103
C12-KKK-NH2 >2·10
3 1·103 1·103 1·103 512 1·103 >2·103 >2·103
C12-KKKK-NH2 256 256 >2·10
3 1·103 2·103 2·103 >2·103 >2·103
C12-KG-NH2 256 512 256 512 256 512 >1·10
3 >2·103
C12-KGK-NH2 >2·10
3 1·103 >2·103 1·103 1·103 1·103 >2·103 >2·103
C12-KGKG-NH2 2·10
3 2·103 2·103 2·103 1·103 1·103 >2·103 >2·103
C10-K-NH2 1·10
3 1·103 1·103 1·103 512 1·103 >2·103 >2·103
C10-KK-NH2 >2·10
3 >2·103 >2·103 >2·103 2·103 2·103 >2·103 >2·103
C10-KKK-NH2 >2·10
3 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103
C10-KKKK-NH2 >2·10
3 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103
C10-KG-NH2 >2·10
3 >2·103 1·103 2·103 1·103 2·103 >2·103 >2·103
C10-KGK-NH2 >2·10
3 >2·103 >2·103 >2·103 2·103 2·103 >2·103 >2·103
C10-KGKG-NH2 >2·10
3 >2·103 2·103 2·103 1·103 2·103 >2·103 >2·103
C8-K-NH2 >1·10
3 >1·103 >1·103 >1·103 >2·103 >2·103 >2·103 >2·103
C8-KK-NH2 >1·10
3 >1·103 >1·103 >1·103 >2·103 >2·103 >2·103 >2·103
C8-KKK-NH2 >2·10
3 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103
C8-KKKK-NH2 >1·10
3 >1·103 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103
C8-KG-NH2 >2·10
3 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103
C8-KGK-NH2 >2·10
3 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103
C8-KGKG-NH2 >2·10
3 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103 >2·103




The antimicrobial tests indicated that lipopeptides containing
hexadecanoic acid residue reveal high antibacterial activity
toward Gram positives andGram negatives; however, this activity
is higher toward Gram positive bacteria (Tables 2, 3). The most
potent bacteriostatic effect was observed with analogs containing
more than one basic amino acid, that is C16-KK-NH2, C16-
KKK-NH2, C16-KKKK-NH2, C16-KGK-NH2, and C16-KGKG-
NH2. It was demonstrated that lipopeptides inhibit the growth
of G+ and G− in the concentration range of 4–16 µg/mL.
The exception is the P. vulgaris strain, which is resistant to the
most active palmitate analogs and its MIC value reaches 512
µg/mL for all lipopeptide analogs. The lowest growth inhibition
of G− was recorded for lipopeptides containing one basic
amino acid: C16-K-NH2 and C16-KG-NH2. Results obtained for
lipopeptides modified with tetradecanoic acid varied depending
on the tested strain. The compounds exhibited relatively high
antibacterial activity toward B. subtilis and S. epidermidis.
The strongest bacteriostatic effect, from 4 to 8 µg/mL, was
observed for the analogs C14-KK-NH2 and C14-KKK-NH2.
Moderate bacteriostatic activity against the remaining Gram
positive bacteria and Gram negatives was found (Tables 2, 3).
However the activity toward gram-positive strains was higher
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in comparison to gram-negative strains. Lipopeptides modified
with dodecanoic acid revealed rather poor bacteriostatic activity
against tested G+ and G− strains (Tables 2, 3). Among all of
the dodecanoic analogs, the highest growth inhibitory activity
was perceived for lipopeptides containing one basic amino
acid, i.e., C12-K-NH2 or C12-KG-NH2. MIC values determined
for these compounds toward G+ and G− are in the range
of 128–256 µg/mL, but for the strain P. vulgaris MIC was
found at 512 µg/mL. Lipopeptides with two and three lysine
residues (C12-KK-NH2, C12-KKK-NH2) are characterized by
irregular activity. They are bacteriostatic to S. epidermidis and
B. subtillis at a concentration of 64 µg/mL, but to S. aureus at
a concentration of 2 and 1 mg/mL, respectively. The compounds
are practically inactive against strains G−. Lipopeptides modified
with decanoic acid are characterized by either poor bacteriostatic
activity against G+ and G− strains or a complete lack
thereof (Tables 2, 3). Among these lipopeptides, some higher
bacteriostatic effect against G+ was observed for analogs C10-
KKK-NH2 and C10-KKKK-NH2. They are also moderately active
toward S. epidermidis and B. subtillis, while S. aureus and E.
fecalis strains revealed complete resistance to them. None of the
obtained lipopeptides modified with decanoic acid inhibited the
growth of tested Gram negatives. Only the C10-K-NH2 analog
exhibited very poor activity toward the P. aeruginosa strain; MIC
value was observed at 512 µg/mL. Lipopeptides with attached
octanoic fatty acid are generally inactive against gram positives
as well as gram negatives. Among the 7 synthesized compounds,
bacteriostatic activity at the concentration of 256 µg/mL toward
S. epidermidis was noticed for C8-KKK-NH2 and C8-KGK-NH2.
Additionally, C8-KGK-NH2 was bacteriostatic to B. subtillis at
the concentration of 512µg/mL.
Characterization of Bactericidal Properties
The highest bactericidal activity was revealed for lipopeptides
modified with hexadecanoic acid. C16-KK-NH2, C16-KKK-
NH2, C16-KKKK-NH2, C16-KGK-NH2, and C16-KGKG-NH2
are bactericidal to G+ and G− in a concentration range similar
to MIC, i.e., from 4 to 32 µg/mL. The bactericidal activity of
the analogs containing one lysine residue (C16-K-NH2 or C16-
KG-NH2) is distinctly lower. Although, S. epidermidis, B. subtillis
and E. fecalis are already sensitive to these at a concentration
of 4–64 µg/mL; unlike S. aureus, which is sensitive only at
512 µg/mL. For G− bacteria, much weaker bactericidal activity
was observed. MBC values of compounds where the total net
charge of the molecule is +1 reach 256–1·103 µg/mL. Selected
myristates as well as palmitates exhibit good bactericidal activity.
The obtained MBC values were usually as much as twice as high
as the MICs. The strongest bactericidal effect was proven for
analogs of C14-KK-NH2 and C14-KKK-NH2. The most sensitive
strains are B. subtillis and S. epidermidis. MBC determined for
these organisms is within the range of 4–8 µg/mL. MBC of the
lipopeptides C12-K-NH2 and C12-KG-NH2 is only the same as
MIC for S. epidermidis and E. fecalis. For strains of S. aureus
and B. subtillis, MBC is twice as high as MIC. Lipopeptides
containing two or three lysine residues (C12-KK-NH2, C12-
KKK-NH2) are weakly bactericidal to all of the studied gram
negatives. Most susceptible to C12-KKK-NH2 was P. aeruginosa;
MBC was observed at 512 µg/mL. None of the decanoic analogs
have any bactericidal activity against S. aureus and E. fecalis.
Strains of S. epidermidis and B. subtillis are more sensitive, in
particular to C10-KKK-NH2 and C10-KKKK-NH2, and MBC
values determined for these compounds range 128–256 µg/mL.
From MBC values it can be concluded that decanoic modified
lipopeptides are not bactericidal toward the tested strains. The
MBC test demonstrated that only C8-KKK-NH2 was bactericidal
to S. epidermidis at the concentration of 512µg/mL.
Characterization of Antifungal Properties
It was found that palmitic acid derived peptides are weakly
active against Candida species and Aspergillus molds (Table 4).
This was confirmed by MIC and MFC determination. Of the
seven analogs, the best fungistatic properties were confirmed
for C16-KK-NH2, C16-KKK-NH2, and C16-KKKK-NH2. Both
the MIC and the MFC are 128 µg/mL. Analogs containing
glycine in the sequence (i.e., C16-KG-NH2, C16-KGK-NH2,
and C16-KGKG-NH2) show weaker activity against C.
tropicalis and A. brasiliensis. The lowest antifungal activity
among all hexadecanoic analogs was revealed for lipopeptides
containing one lysine: C16-K-NH2. Lipopeptides modified with
tetradecanoic acid revealed some fungistatic and fungicidal
activity against Candida and Aspergillus species. The lowest
MIC and MBC value, i.e., 64 µg/mL, toward A. brasiliensis was
noted in two cases: C14-KKK-NH2 and C14-KKKK-NH2. These
compounds inhibit the growth of C. albicans and C. tropicalis
slightly less effectively, because they require a concentration
twice as high—128 µg/mL (Table 4). It was found that, at the
same concentrations, all the tetradecanoic lipopeptides are
fungistatic and fungicidal to the tested strains of C. albicans, C.
tropicalis and A. brasiliensis. It was observed that dodecanoic
lipopeptides weakly inhibits the growth of yeasts of Candida
and A. brasiliensis (Table 4). The most bacteriostatically efficient
compound proved to be that containing four lysines—C12-
KKKK-NH2; MIC of this compound is in the range 128–256
µg/mL. Nearly identical properties were demonstrated by C12-
K-NH2. Other analogs did not show significant bacteriostatic
activity toward the tested fungi species. The best MFC results
were observed for C12-KKKK-NH2. Analogs C12-K-NH2 and
C12-KG-NH2 presented the same fungicidal activity—512
µg/mL. Generally, decanoic lipopeptides revealed no fungistatic
activity toward Candida species and A. brasiliensis (Table 4).
Some very weak fungistatic effect at the concentration of 512
µg/mL was noticed for C10-KGK-NH2 and C10-KGKG-NH2
toward C. tropicalis and for C10-K-NH2 toward A. brasiliensis.
All tested fungi were totally resistant to octanoic analogs, as
can be seen from the high MIC and MFC values. Results of
antimicrobial studies are presented in Tables 2–4.
Influence of the Presence of TFA on the
Antimicrobial Activity
The most promising compounds, i.e., lipopeptides containing
palmitic and myristic fatty acid residues, were tested after
removal of counter ions to determine whether this influences
their antimicrobial activity. We noticed some differences in the
activity of compounds toward various strains. The determined
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TABLE 4 | Antimicrobial activity toward fungi strains and toxicity toward human red blood cells.
Lipopeptides Candida albicans Candida tropicalis Aspergillus brasiliensis Hemolysis
MIC MFC MIC MFC MIC MFC HC10
C16-K-NH2 512 512 >512 >512 >512 >512 512
C16-KK-NH2 128 128 128 128 128 128 16
C16-KKK-NH2 128 128 128 128 128 128 32
C16-KKKK-NH2 128 128 128 128 128 128 16
C16-KG-NH2 128 128 256 512 512 512 256
C16-KGK-NH2 128 128 256 256 128 128 64
C16-KGKG-NH2 128 128 256 256 128 128 64
C14-K-NH2 512 512 >512 >512 512 512 512
C14-KK-NH2 128 128 256 256 256 256 128
C14-KKK-NH2 128 128 128 128 64 64 256
C14-KKKK-NH2 128 128 128 128 64 64 256
C14-KG-NH2 128 128 256 256 128 128 >1·10
3
C14-KGK-NH2 128 128 256 256 128 128 128
C14-KGKG-NH2 128 128 512 512 128 128 512
C12-K-NH2 256 512 256 512 256 512 1·10
3
C12-KK-NH2 1·10
3 2·103 1·103 2·103 2·103 2·103 >4·103
C12-KKK-NH2 1·10
3 1·103 1·103 1·103 512 512 512
C12-KKKK-NH2 256 256 256 512 128 256 1·10
3
C12-KG-NH2 512 512 512 512 256 512 1·10
3
C12-KGK-NH2 2·10
3 2·103 2·103 2·103 1·103 2·103 1·103
C12-KGKG-NH2 1·10
3 2·103 1·103 2·103 1·103 1·103 256
C10-K-NH2 1·10
3 2·103 1·103 2·103 512 1·103 >4·103
C10-KK-NH2 2·10
3 2·103 1·103 1·103 1·103 1·103 4·103
C10-KKK-NH2 2·10
3 2·103 2·103 2·103 1·103 2·103 >4·103
C10-KKKK-NH2 >2·10
3 >2·103 2·103 2·103 2·103 2·103 >4·103
C10-KG-NH2 1·10
3 2·103 1·103 2·103 1·103 2·103 >4·103
C10-KGK-NH2 1·10
3 1·103 512 1·103 1·103 1·103 >4·103
C10-KGKG-NH2 1·10
3 2·103 512 2·103 1·103 2·103 >4·103
C8-K-NH2 1·10
3 1·103 1·103 2·103 1·103 1·103 >4·103
C8-KK-NH2 1·10
3 1·103 1·103 1·103 1·103 1·103 >4·103
C8-KKK-NH2 2·10
3 2·103 2·103 2·103 2·103 2·103 >4·103
C8-KKKK-NH2 2·10
3 2·103 2·103 2·103 2·103 2·103 >4·103
C8-KG-NH2 2·10
3 2·103 2·103 2·103 2·103 2·103 >4·103
C8-KGK-NH2 2·10
3 2·103 2·103 2·103 2·103 2·103 >4·103
C8-KGKG-NH2 2·10
3 2·103 2·103 2·103 2·103 2·103 >4·103
MIC, MFC and MHC are expressed as µg/mL.
HC10 – concentration of lipopeptide inducing 10% of hemolysis.
antimicrobial activity was usually either the same for compounds
with and without TFA or 2-fold higher/ lower, depending on
the compounds and strain tested. For S. aureus, palmitic analogs
without TFA (with the exception of C16-K-NH2) were twice
as active as compounds containing TFA in both MIC and
MBC assays. MICs obtained for C14-KK-NH2 and C14-KKK-
NH2 were also twice as low as those obtained for lipopeptides
after TFA removal. For the compounds C14-KGK-NH2 and
C14-KGKG-NH2 the same difference was observed, but for the
MBC values. Similar results were obtained with the E. faecalis
strain. For almost all palmitic analogs without counter ions, the
bacteriostatic and bactericidal concentrations were twice as low
as peptides containing TFA. For myristic analogs, we did not
observe any discrepancies in the activity of compounds both
before and after removal of the counter ion. Bactericidal activity
of the majority of palmitic analogs without TFA against E. coli
was twice as high as peptides with a counter ion. MIC values
were different for palmitic analogs containing glycine and more
than one lysine residues. Bacteriostatic activity was also higher
for myrisitic analogs: C14-K-NH2, C14-KK-NH2, and C14-KKK-
NH2. For K. pneumoniae, differences between the activity of the
compounds after counter ion removal were noticed only for a few
compounds. ObtainedMBCswere lower for lipopeptides without
TFA, i.e., C16-K-NH2, C16-KKKK-NH2, and C14-KKKK-NH2,
while for compounds C16-KGK-NH2, C16-KGKG-NH2, and
C14-KG-NH2 we observed a decrease in antibacterial activity
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FIGURE 1 | Example of FTIR spectra of lipopeptide C16-KK-NH2 before TFA counter ion removal (Green Line) and after TFA counter ion removal
(blue line).
after removal of TFA. A decrease in the activity of compounds
without counter ions was observed for the majority of the tested
myristic analogs in MIC and MBC tests with C. albicans.
Hemolysis
Lytic activity against human erythrocytes was measured to assess
the toxicity of lipopeptides to eukaryotic cells. Lipopeptides
containing a hexadecanoic chain displayed strong hemolysis.
The strongest toxicity was demonstrated by palmitic derivatives
containing more than one lysine residue: C16-KK-NH2,
C16-KKKNH2, and C16-KKKK-NH2 (MHC 16–32 µg/mL).
Compounds with the same cationic charge additionally
containing a glycine residue showed slightly reduced lytic
activity (MHC 64 µg/mL). Among the group of lipopeptides
with a tetradecanoic acid, two analogs—C14-KK-NH2 and
C14-KGK-NH2—were established as moderately hemolytic.
These lead to lysis of red blood cells at the concentration of
128 µg/mL. Compounds containing 3 or 4 basic amino acid
destroy erythrocytes at a higher concentration, i.e., only at 256
µg/mL. The rest of the synthesized lipopeptides are very weakly
hemolytic or display no hemolysis at all within the range of
the tested concentrations. The study shows that the hemolytic
activity of lipopeptides increases with the length of the attached
hydrophobic chain. Among the synthesized lipopeptides, the
greatest hemolytic activity was observed for hexadecanoic
modified lipopeptides. For those lipopeptides comprising a
fragment of octanoic acid, hemolysis was not observed, even at a
concentration of 4·103 µg/mL. Furthermore, within the group of
lipopeptides with a hexadecanoic fatty acid a strong dependence
of the hemolytic activity on amino acid composition of the
hydrophilic portion of the molecule was observed. Compounds
endowedwith a greater positive charge weremore toxic to human
erythrocytes.
TFA Removal and Antibacterial Activity of
Lipopeptides without a Counter Ion
Since the most significant antimicrobial activities were observed
for lipopeptides containing hexadecanoic and tetradecanoic
hydrocarbon chains, only those two groups of compounds were
subjected to TFA counter ion removal to test the influence of TFA
presence on the antimicrobial activity of lipopeptides themselves.
Obtained FTIR spectra confirmed the absence of TFA counter
ions, thus proving that the process of removing the counter ions
via a VariPure IPE ion-exchange column ran properly. Figure 1
presents IR spectra of lipopeptides before (green line) and after
(blue line) TFA removal. There are visible bands derived from
the stretching vibration of CF2 and CF3 groups within the range
of 1350–1120 cm−1 (green line). However, there is no such band
in the sample subjected to removal of the counter ion.
DISCUSSION
The antimicrobial activity of synthetic cationic lipopeptides is
widely studied and many structures have already been described.
For example, ultrashort lipopeptides very similar to ours,
composed of lysine, glycine, alanine, leucine and isoleucine
acylated with dodecanoic, tetradecanoic, and hexadecanoic
acids were synthesized. For each of the ultrashort lipopeptides,
one amino acid of D-configuration was introduced. The best
MIC values were obtained for the compound C16-KGG-[D]-K-
NH2. This was found to be active toward G− and G+ tested
strains (Makovitzki et al., 2006). We obtained similar results
for palmitic derivatives. The compounds exhibited very potent
Frontiers in Microbiology | www.frontiersin.org 8 February 2017 | Volume 8 | Article 123
Greber et al. Cationic Lipopeptides as Potential Antimicrobials
TABLE 5 | Antimicrobial activity of lipopeptides without TFA counter ion, expressed as minimum inhibitory concentration and minimum
bactericidal/fungicidal concentration.
Lipopeptides Staphylococcus aureus Enterococcus fecalis Escherichia coli Klebsiella pneumoniae Candida albicans
MIC MBC MIC MBC MIC MBC MIC MBC MIC MFC
C16-K-NH2 128 128 32 32 512 512 512 512 512 512
C16-KK-NH2 4 4 4 4 4 4 16 32 256 256
C16-KKK-NH2 4 8 8 8 4 8 4 4 128 128
C16-KKKK-NH2 4 4 4 8 8 8 4 4 128 128
C16-KG-NH2 4 4 4 8 256 256 128 256 128 128
C16-KGK-NH2 4 4 4 4 4 4 32 64 128 128
C16-KGKG-NH2 8 16 16 16 8 8 16 32 128 128
C14-K-NH2 64 64 64 64 64 128 64 512 512 512
C14-KK-NH2 32 64 32 32 32 64 128 128 256 256
C14-KKK-NH2 32 32 32 64 128 128 128 256 256 256
C14-KKKK-NH2 128 128 64 64 256 256 128 128 256 256
C14-KG-NH2 32 32 32 32 64 64 32 64 256 256
C14-KGK-NH2 64 64 64 64 128 128 64 64 128 128
C14-KGKG-NH2 64 64 64 64 128 128 128 128 256 256
MIC, MBC and MFC are expressed as µg/mL.
antibacterial activity, but unfortunately they turned out to
be also the most toxic to human erythrocytes. Due to their
hemolytic activity only topical application can be considered.
However, in some previous studies the compound C16-KK-NH2
exhibited toxicity toward human keratinocytes HaCaT exposed
to its microbiologically active concentrations (Baran´ska-Rybak
et al., 2013). Therefore, further consideration of this compound
should be as a topical agent applied on uninjured skin, e.g.,
eradication of bacterial colonization, or as a preservative
for dermatological drugs or cosmetics. For abovementioned
ultrashort lipopeptides, similarly to our results, strong hemolytic
activity, at the level of 8% at 20 µM, was observed. It seems
that these lipopeptides do not discriminate effectively between
bacterial and eukaryotic cells. Some better results have been
obtained for myristic residues.We observed some discrimination
between various microbial species, which would suggest some
additional mechanism of antibacterial action. However, the
toxicity is still at a relatively high level and to improve the
selectivity of the lipopeptide antibiotic structure modifications
are needed. A possible solution is also the use of a combination
of active lipopeptides with conventional antibiotics, which
would probably allow the use of lower concentrations of both
substances (Barchiesi et al., 2007; Cirioni et al., 2007; Simonetti
et al., 2009). According to the literature, the anti-infective
activity of C16-KK-NH2 has been studied utilizing the rat
model, where the compound demonstrated effectiveness against
induced staphylococcal infections, at the same time without
causing harmful side effects in the test animals. Kamysz et al.
studied the activity of C16-KK-NH2 and C16-KK-OH against
gram-positive cocci resistant to methicillin and vancomycin. The
tested compounds showed high antimicrobial activity against
these strains and a slightly synergistic effect in combination
with amoxicillin, imipenem and vancomycin (Kamysz et al.,
2007). The antibacterial activity of selected lipopeptides
was also determined against clinical isolates of S. aureus.
The tested compounds, i.e., C16-KK-NH2, C16-KKK-NH2,
C16-KKKK-NH2, C16-KG-NH2 and C16-KGK-NH2, showed
high antistaphylococcal activity against all tested strains,
including those resistant to chloramphenicol, erythromycin and
penicillin. G. Sarig et al. received a lipopeptide composed of three
residues of lysine and two hydrocarbon chains (C12-KK-C12-
K-NH2), wherein one of the hydrophobic chains separated the
amino acid sequence into two parts. For this compound, a very
high antimicrobial activity against S. aureus strains was found
(2.5–5 µg/mL) and a weaker one against E. coli (≥ 40 µg/mL)
(Sarig et al., 2010).
There is not much available data in the literature regarding the
impact of counter ions on the biological activity of antimicrobial
peptides obtained via chemical synthesis. However, Gaussier
et. al. revealed that replacement of trifluoroacetic acid with
HCl counter ions did not significantly affect the antimicrobial
activity of pediocin PA-1 (Gaussier et al., 2002). In our study,
the removal of TFA either caused no change in activity or
the results differed by one well (Table 5). In the majority of
cases, the obtained MICs and MBCs were lower for lipopeptides
without counter ions. This might be a result of the different
molecular weights of the two peptide forms, rather than being a
direct influence on antimicrobial action. However, in a few cases
peptides containing TFA were slightly more active toward K.
pneumoniae and C. albicans, which would suggest some positive
influence on antimicrobial activity. However, further study with
the use of other counter ions and more microbial species is
needed to clarify this issue.
CONCLUSIONS
We have demonstrated that the antimicrobial activity of short
cationic lipopeptides is strongly dependent on the net charge
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of the lipopeptide molecule. A higher antibacterial activity is
displayed by lipopeptides with a net charge from +2 to+4 and a
hexadecanoic fatty acid chain attached. This clearly suggests that
a antimicrobial peptide molecule needs proper balance between a
hydrophilic and hydrophobic entity to effectively interact with a
bacterial membrane. Our studies also clarify that the presence of
a TFA counter ion has no significant impact on the antimicrobial
activity of the tested lipopeptides.
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